Jiangsu Jibeier Pharmaceutical Co. Ltd.SSE: 688566

Report for Q1 2026

Apr 28, 2026 · Issued by Jiangsu Jibeier Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 28, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-634

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Jiangsu Jibeier Pharmaceutical Co. Ltd. on 6ix

Earlier from Jiangsu Jibeier Pharmaceutical

Announcement on Adjusting Grant Price of Restricted Stocks in 2025 Restricted Stock Incentive PlanApr 11
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Completion of Certain IPO Fundraising Projects with Permanent Replenishment of Remaining Funds and Adjustment of Implementation Progress for Certain IPO Fundraising ProjectsDec 30, 2025
Announcement on Convening the Q3 2025 Performance BriefingNov 8, 2025
Report for Q3 2025Oct 31, 2025

Later from Jiangsu Jibeier Pharmaceutical

Announcement on Resolutions of the 22nd Meeting of the 4th Board of DirectorsMay 21
Announcement on Resolutions of the 2025 Annual General MeetingMay 23
Announcement on Vesting Results and Share Listing in the 1st Vesting Period of Initial Grant in 2025 Restricted Stock Incentive PlanJun 5
Announcement on Adjusting the Total Profit Distribution in 2025Jun 11
Announcement on Voluntary Disclosure of Obtaining Invention Patent CertificateJun 16

All Jiangsu Jibeier Pharmaceutical news releases

Follow Jiangsu Jibeier Pharmaceutical into a list and get an email when it puts out news.

Follow Jiangsu Jibeier Pharmaceutical